Reporting Checklist for Nature Neuroscience

Transcription

1 Corresponding Author: Manuscript Number: Manuscript Type: Roger Thompson NNA52598C Article Reporting Checklist for Nature Neuroscience # Main Figures: 7 # Supplementary Figures: 9 # Supplementary Tables: 0 # Supplementary Videos: 0 This checklist is used to ensure good reporting standards and to improve the reproducibility of published results. For more information, please read Reporting Life Sciences Research. Please note that in the event of publication, it is mandatory that authors include all relevant methodological and statistical information in the manuscript. Statistics reporting, by figure example example Please specify the following information for each panel reporting quantitative data, and where each item is reported (section, e.g. Results, & paragraph number). Each figure legend should ideally contain an exact sample size (n) for each experimental group/condition, where n is an exact number and not a range, a clear definition of how n is defined (for example x cells from x slices from x animals from x litters, collected over x days), a description of the statistical used, the results of the s, any descriptive statistics and clearly defined error bars if applicable. For any experiments using custom statistics, please indicate the used and stats obtained for each experiment. Each figure legend should include a statement of how many times the experiment shown was replicated in the lab; the details of sample collection should be sufficiently clear so that the replicability of the experiment is obvious to the reader. For experiments reported in the text but not in the figures, please use the paragraph number instead of the figure number. Note: Mean and standard deviation are not appropriate on small samples, and plotting independent data points is usually more informative. When technical replicates are reported, error and significance measures reflect the experimental variability and not the variability of the biological process; it is misleading not to state this clearly. FIGURE NUMBER 1a results, TEST USED WHICH TEST? oneway ANOVA unpaired t Fig. legend Results EXACT VALUE 9, 9, 10, 15 n DEFINED? mice from at least 3 litters/group 15 slices from 10 mice Methods para 8 Results DESCRIPTIVE STATS (AVERAGE, VARIANCE) REPORTED? error bars are mean / SEM error bars are mean / SEM Fig. legend Results P VALUE EXACT VALUE p = p = Fig. legend Results DEGREES OF FREEDOM & F/t/z/R/ETC VALUE VALUE F(3, 36) = 2.97 t(28) = Fig. legend Results 1

2 FIGURE NUMBER 1e 1f 1h (left) 1h (right ) 2e 2g,j 3b 3c 3d (left) 3d (right ) 4b (top) TEST USED WHICH TEST? twoway twoway twoway twoway oneway twoway, unpaired Student's t paired Student's t oneway twoway twoway oneway EXACT VALUE n DEFINED? DESCRIPTIVE STATS (AVERAGE, VARIANCE) REPORTED? P VALUE EXACT VALUE Fig 1 6, 7, 5, 6 slices from 16 rats Fig. 1 mean / SEM Fig 1 p < Fig 1 Fig 1 6, 7, 5, 6 slices from 16 rats Fig. 1 mean / SEM Fig 1 p=0.9429, p< Fig 1 7, 9 slices from 7 rats Fig. 1 mean / SEM Fig 1 p< Fig 1 Fig 1 7, 9 slices from 7 rats Fig. 1 mean / SEM Fig 1 p< Fig 1 5, 6, 12, 6, 7, 7 7 (g), 7, 9 Fig 1 slices from 22 rats mean / SEM p< slices from 3(g) and 7(j) rats mean / SEM 5 slices from 3 rats mean / SEM 6, 4, 6 slices from 7 rats mean / SEM 6, 4, 6 slices from 7 rats mean / SEM 6, 4, 6 slices from 7 rats mean / SEM 3, 3, 3, 3 slices from 3 rats mean / SEM p<0.001, p=0.0002, p= p=0.009, p=0.0113, p= p=0.0084, p= p=0.0228, p= p=0.3409, p= p=0.0354, p=0.9734, p= DEGREES OF FREEDOM & F/t/z/R/ETC VALUE VALUE DF=62, t=16.547, t=9.895, t=7.170, t= DF=52, t=0.7927, t=9.281, t=10.06, t=8.247, t=8.932 DF=50, t=8.884 DF=50, t=7.78 DF=31, q=6.798, q=13.13 q=12.13 q=5.855, q=6.080 DF=24, t=6.459, t=4.722, DF=12 t=2.095 DF=4, t=4.752, t=4.445, t=1.633 DF=12, q=5.186, q=2.934 DF=30, t=4.210, t=3.060 DF=30, t=1.701, t=1.456 DF=8 q=4.878 q= q=4.560 Fig 1 Fig 1 Fig 1 Fig 1 4b (bott om) oneway 3, 3, 3, 3 slices from 3 rats mean / SEM p=0.0336, p=0.9979, p= DF=8 q=4.932 q= q=

3 4c 4e 4f 5a 5b 5c 5e 5f 5h 5i 6b 6c unpaired Student's t twoway twoway oneway oneway oneway (compare to NMDA stim) oneway unpaired Student's t twoway twoway unpaired Student's t oneway 9, 7 slices from 8 rats mean / SEM p= , 7 slices from 7 rats mean / SEM p< , 7 slices from 7 rats mean / SEM p< , 5, 5, 5 slices from 5 rats mean / SEM 3, 3, 3, 3 TOP: 3, 3, 3, 3, 3, 3, 3, 3, 3, 3 BOTTOM : 5, 5, 5, 5, 5, 5, 5, 5, 5, 5 TOP: 5, 5, 5, 5 BOTTOM: 4, 4, 4, 4 experiments on cell culture, 12 wells experiments on cell culture, 80 wells mean / SEM mean / SEM slices from 9 rats mean / SEM p=0.0035, p=0.0021, p> p=0.0093, p=0.9606, p= TOP: p=0.0052, p=0.9102, p=0.3150, p=0.0093, p=0.9567, p= BOTTOM: p=0.031, p>0.9999, p>0.9999, p=0.0185, p>0.9999, p> TOP: p=0.0164, p>0.9999, p= BOTTOM: p=0.0033, p>0.9999, p= , 6 slices from 8 rats mean / SEM p= , 6 slices from 8 rats mean / SEM p< , 6 slices from 8 rats mean / SEM p< , 177, 85, 102, 123, , 177, 85, 102, 123, 146 cells from 31 culture dishes cells from 31 culture dishes mean / SEM mean / SEM p=0.0007, p< p=0.7791, p<0.0001, p=0.0002, p< DF=13, t=2.012 DF=26, t=5.053 DF=26, t=6.107 DF=16 q=5.929 q=6.277 q= DF=8 q=6.273 q= q= TOP: DF=16 q=4.630 q=1.232 q=2.375 q=4.333 q=1.059 q=4.882 BOTTOM: DF=32 q=3.061 q= q=1.283 q=3.260 q= q=0.475 TOP: DF=16 q=3.210 q= q=2.813 BOTTOM: DF=12 q=4.266 q= q=4.640 DF=9, t=2.049 DF=50, q=4.934 DF=50, q=6.750 DF=461, t=5.680, t=8.144, t=9.313 DF=25 q=1.847, q=7.565, q=8.902, q=

4 6f 7b 7c 7f 7g 7h 5j 2m oneway (compare to OGD) oneway twoway 's oneway 's oneway 's oneway 's oneway oneway 80, 39, 33, 21, 21, 23, 22 6, 7, 4, 7, 12, 5, 11 6, 4, 6, cells from 45 culture dishes mean / SEM Slices from 52 rats mean / SEM Assessment of 19 rats recordings from 5 rats recordings from 5 rats recordings from 5 rats mean / SEM p=0.0164, p=0.0016, p=0.0081, p=0.0304, p< p=0.3064, p=0.0005, p= p=0.9995, p=0.0168, p= p=0.0324, p=0.0029, p=0.0402, p=0.0011, p= p=0.0098, p= mean / SEM p> mean / SEM p> mean / SEM p> , 4, 4, 4 slices from 4 rats mean / SEM 7, 8, 8 cells from 23 culture dishes mean / SEM p=0.005, p=0.0011, p= fluorescence: p=0.0007, p=0.0012, p= Charge: p=0.0055, p=0.0024, p= DF=255, q=4.838, q=5.764, q=5.143, q=4.562, q=7.065, q=6.789 DF=43, q=2.175, q=7.383, q=4.413, q=0.5943, q=4.970, q=4.550 DF=272, t=2.805, t=3.528, t=2.733, t=3.788, t= 2.722, t=3.181, t=3.094 DF=4, t=0.8814, t=0.8428, t=1.246, t= DF=4, t=0.5548, t=0.6468, t=0.1590, t= DF=4, t=0.4421, t=0.5786, t= , t= DF=12 q=6.076 q=7.314 q=5.767 DF=19, t=4.515, t=4.241, t= DF=20, t=3.084, t=4.423, t=

5 Representative figures 1. Are any representative images shown (including Western blots and immunohistochemistry/staining) in the paper? If so, what figure(s)? 2. For each representative image, is there a clear statement of how many times this experiment was successfully repeated and a discussion of any limitations in repeatability? If so, where is this reported (section, paragraph #)? Statistics and general methods 1. Is there a justification of the sample size? If so, how was it justified? Even if no sample size calculation was performed, authors should report why the sample size is adequate to measure their effect size. 2. Are statistical s justified as appropriate for every figure? a. If there is a section summarizing the statistical methods in the methods, is the statistical for each experiment clearly defined? b. Do the data meet the assumptions of the specific statistical you chose (e.g. normality for a parametric )? Where is this described (section, paragraph #)? c. Is there any estimate of variance within each group of data? Is the variance similar between groups that are being statistically compared? Fig 1a, b, c, d, g a, b, c, e, f a, b a, d a, b, c, d, j a, d, e a, d, e Supp a, c Supp a, d, e Supp a, b, c, d Supp a Supp a Supp a Yes. All representative data shown are from data sets used for statistical analysis. These data are all reported in the figure legends. No, we do not include justification for sample sizes. Sample sizes were determined based on the minimum number of animals for statistical significance to levels of at least p < Yes, statistical s used in this manuscript are described in the Data Analysis section. Yes. Where is this described (section, paragraph #)? d. Are s specified as one or twosided? Yes. 5

6 e. Are there adjustments for multiple comparisons? Yes. 3. Are criteria for excluding data points reported? Was this criterion established prior to data collection? Where is this described (section, paragraph #)? 4. Define the method of randomization used to assign subjects (or samples) to the experimental groups and to collect and process data. If no randomization was used, state so. Where does this appear (section, paragraph #)? 5. Is a statement of the extent to which investigator knew the group allocation during the experiment and in assessing outcome included? If no blinding was done, state so. 6. For experiments in live vertebrates, is a statement of compliance with ethical guidelines/regulations included? 7. Is the species of the animals used reported? 8. Is the strain of the animals (including background strains of KO/ transgenic animals used) reported? 9. Is the sex of the animals/subjects used reported? 10. Is the age of the animals/subjects reported? 11. For animals housed in a vivarium, is the light/dark cycle reported? 12. For animals housed in a vivarium, is the housing group (i.e. number of animals per cage) reported? We did not exclude data points. Skilled reaching tasks to assess neuroprotective efficacy of TAT Panx308 were blinded (Figure 7). No. 13. For behavioral experiments, is the time of day reported (e.g. light or dark cycle)? 6

7 14. Is the previous history of the animals/subjects (e.g. prior drug administration, surgery, behavioral ing) reported? a. If multiple behavioral s were conducted in the same group of animals, is this reported? 15. If any animals/subjects were excluded from analysis, is this reported? Reagents a. How were the criteria for exclusion defined? Where is this described (section, paragraph #)? b. Specify reasons for any discrepancy between the number of animals at the beginning and end of the study. Where is this described (section, paragraph #)? 1. Have antibodies been validated for use in the system under study (assay and species)? a. Is antibody catalog number given? Where does this appear (section, paragraph #)? b. Where were the validation data reported (citation, supplementary information, Antibodypedia)? Where does this appear (section, paragraph #)? 2. Cell line identity a. Are any cell lines used in this paper listed in the database of commonly misidentified cell lines maintained by ICLAC and NCBI Biosample? b. If yes, include in the Methods section a scientific justification of their useindicate here in which section and paragraph the justification can be found. Validation is also included as a supplementary figure. 7

8 c. For each cell line, include in the Methods section a statement that specifies: the source of the cell lines have the cell lines been authenticated? If so, by which method? have the cell lines been ed for mycoplasma contamination? Data deposition Data deposition in a public repository is mandatory for: a. Protein, DNA and RNA sequences b. Macromolecular structures c. Crystallographic data for small molecules d. Microarray data Deposition is strongly recommended for many other datasets for which structured public repositories exist; more details on our data policy are available here. We encourage the provision of other source data in supplementary information or in unstructured repositories such as Figshare and Dryad. We encourage publication of Data Descriptors (see Scientific Data) to maximize data reuse. 1. Are accession codes for deposit dates provided? Computer code/software No we reference the original articles for primer sequences that we used. We will happily include them if needed. Any custom algorithm/software that is central to the methods must be supplied by the authors in a usable and readable form for readers at the time of publication. However, referees may ask for this information at any time during the review process. 1. Identify all custom software or scripts that were required to conduct the study and where in the procedures each was used. 2. If computer code was used to generate results that are central to the paper's conclusions, include a statement in the Methods section under "Code availability" to indicate whether and how the code can be accessed. Include version information as necessary and any restrictions on availability. Human subjects 1. Which IRB approved the protocol? Where is this stated (section, paragraph #)? 2. Is demographic information on all subjects provided? 8

9 3. Is the number of human subjects, their age and sex clearly defined? 4. Are the inclusion and exclusion criteria (if any) clearly specified? 5. How well were the groups matched? Where is this information described (section, paragraph #)? 6. Is a statement included confirming that informed consent was obtained from all subjects? 7. For publication of patient photos, is a statement included confirming that consent to publish was obtained? fmri studies For papers reporting functional imaging (fmri) results please ensure that these minimal reporting guidelines are met and that all this information is clearly provided in the methods: 1. Were any subjects scanned but then rejected for the analysis after the data was collected? a. If yes, is the number rejected and reasons for rejection described? 2. Is the number of blocks, trials or experimental units per session and/ or subjects specified? 3. Is the length of each trial and interval between trials specified? 4. Is a blocked, eventrelated, or mixed design being used? If applicable, please specify the block length or how the eventrelated or mixed design was optimized. 5. Is the task design clearly described? 6. How was behavioral performance measured? 7. Is an ANOVA or factorial design being used? 9

10 8. For data acquisition, is a whole brain scan used? If not, state area of acquisition. a. How was this region determined? 9. Is the field strength (in Tesla) of the MRI system stated? a. Is the pulse sequence type (gradient/spin echo, EPI/spiral) stated? b. Are the fieldofview, matrix size, slice thickness, and TE/TR/ flip angle clearly stated? 10. Are the software and specific parameters (model/functions, smoothing kernel size if applicable, etc.) used for data processing and preprocessing clearly stated? 11. Is the coordinate space for the anatomical/functional imaging data clearly defined as subject/native space or standardized stereotaxic space, e.g., original Talairach, MNI305, ICBM152, etc? Where (section, paragraph #)? 12. If there was data normalization/standardization to a specific space template, are the type of transformation (linear vs. nonlinear) used and image types being transformed clearly described? Where (section, paragraph #)? 13. How were anatomical locations determined, e.g., via an automated labeling algorithm (AAL), standardized coordinate database (Talairach daemon), probabilistic atlases, etc.? 14. Were any additional regressors (behavioral covariates, motion etc) used? 15. Is the contrast construction clearly defined? 16. Is a mixed/random effects or fixed inference used? a. If fixed effects inference used, is this justified? 17. Were repeated measures used (multiple measurements per subject)? a. If so, are the method to account for within subject correlation and the assumptions made about variance clearly stated? 18. If the threshold used for inference and visualization in figures varies, is this clearly stated? 19. Are statistical inferences corrected for multiple comparisons? 10

11 a. If not, is this labeled as uncorrected? 20. Are the results based on an ROI (region of interest) analysis? a. If so, is the rationale clearly described? b. How were the ROI s defined (functional vs anatomical localization)? 21. Is there correction for multiple comparisons within each voxel? 22. For clusterwise significance, is the clusterdefining threshold and the corrected significance level defined? Additional comments Additional Comments When we report p values that are not precise (e.g. p<0.0001), we have done so because our statistical analysis software (GraphPad Prism) does not give exact numbers for low p values. p values in chart are reported as treatment vs relevant control. If only one p value is given, it indicates that all treatments achieved the same levels on significance versus control (i.e. when listed as p<0.0001). If multiple p values are reported per row, they are arranged in the order in which they appear in the figure (left to right). 11